According to Data Bridge Market Research new Market report “Global Intra-Uterine Contraceptive Devices Market, By Product Type (Hormonal IUCD, Copper IUCD), By End-User (Hospitals, Gynecology Clinics, Community Healthcare), By Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa) – Trends and Forecast to 2022”, is estimated at USD 3.5 billion in 2015 and is projected to reach USD 4.4 billion by 2022, at a CAGR of 3.5% during the forecast period from 2016 to 2022.Report Access: http://databridgemarketresearch.com/reports/global-intra-uterine-contraceptive-devices-market/
Based on geography the market is segmented into 5 geographical regions which are North America, Europe, Asia-Pacific, South America and rest of the world. The report of this market shares countries like U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa.
The Global Intra-Uterine Contraceptive Market is highly competitive and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report also includes company share analysis for the major companies operating in this market by major regions global, Europe, North America, Asia Pacific and Rest of the World.
The market report contains an in-depth profiling of the key market players, along with the recent developments (New product launches, partnerships, agreements, collaborations, and joint ventures) and strategies adopted by them to sustain and strengthen their positions in the market. Some of the major players operating in this market are Bayer HealthCare AG (A subsidiary of Bayer AG), DKT International, Egemen International, Melbea AG, Teva Pharmaceuticals Industries Ltd., Actavis Plc., Ocon Medical Ltd., Pregna International Limited, Medical Engineering Corporation SA and, SMB Corporation and Meril Life Sciences Pvt. Ltd. among other companies.
Browse Related Reports:
Global Nerve Repair Biomaterials Market, By Product Type (Nerve Repair (Nerve Conduit, Nerve Graft (Allograft, Acellularized Allograft)), Nerve Protection (Nerve Protectors, Nerve Wrap), By Injury Type (Epineural Nerve Repair, Perineural Nerve Repair, Group Fascicular Repair), By End User (Hospital, Clinics, Ambulatory Trauma Centers), By Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa, Rest of the World) – Trends and Forecast to 2022
Global Hemostats Market, By Product Type (Thrombin Based, Combination, Oxidized Regenerated Cellulose Based, Gelatin Based, Collagen Based Hemostat), By Indication (Wound Closure, Surgery), By End-User (Hospitals, Clinics, Ambulatory Centers, Community Healthcare, Others), By Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Trends and Forecast to 2022
4th Floor, Mega Center,
Magarpatta City, Pune – 411028
Visit Data Bridge Blog@ http://databridgemarketresearch.com/blog/
Global Intra-Uterine Contraceptive Devices Market – Industry Trends - Forecast to 2026
Global Intra-uterine Contraceptive Devices Market is Poised to Grow at 3.5% till 2024
Intra-Uterine Contraceptive Devices Market is Expected to reach a Market Value of USD 5.29 billion by 2026
Intra-Uterine Contraceptive Devices Market to Witness High Demand Due to Increasing Unplanned Pregnancies
Global Intra-Uterine Contraceptive Devices Market is Growing at a Significant Rate in the Forecast Period 2018-2025